<DOC>
	<DOCNO>NCT02424019</DOCNO>
	<brief_summary>This study assess safety patient treat ILUVIEN , primary focus IOP .</brief_summary>
	<brief_title>Phase 4 IOP Signals Associated With ILUVIENÂ®</brief_title>
	<detailed_description>The specific objective include study intraocular pressure ( IOP ) relate data patient receive ILUVIEN relate patient 's experience follow prior treatment course corticosteroid result clinically significant IOP elevation .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<criteria>Patients eligible treatment ILUVIEN base Prescribing Information . Patients unable understand sign Informed Consent Form .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>